Searched for
TACROLIMUS CAPSULES
Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...- Stocks in news: DMart, ITC, Hero MotoCorp, Pricol, NHPCAvenue Supermarts, which operates retail chain DMart on Thursday reported a 17% year-on-year jump in its stanalone revenue for the quarter ...
- Dr Reddy's recalls over 8,000 bottles of generic drug in US due to packaging errorDr Reddy's Laboratories is recalling over 8,000 bottles of Tacrolimus capsules from the US market due to a packaging error. The Hyderabad-b...
- Dr Reddy's Lab recalls over 4,000 bottles of generic drug in USNew Jersey-based Dr Reddy's Laboratories Inc, a unit of the company, is recalling the affected lot due to "Presence of one Tacrolimus 1 mg ...
- Biocon reports 17% drop in net profit, Christiane Hamacher steps down as MD of Biocon Biologics“2020 has been one of the most challenging years for the world with an unprecedented pandemic impact on the global economy. We continue to ...
- Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in USThe drug major is recalling esomeprazole magnesium for delayed-release oral suspension in unit dose packets in strengths 10 mg, 20 mg and 4...
- Lupin, Concord Biotech get USFDA nod for generic immunosuppressant capsulesIn alliance with Concord Biotech, the company has received approval from the United States Food and Drug Administration (USFDA) to market T...
- Glenmark Pharma gets USFDA nod for Tacrolimus capsulesGlenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Tacrolimus...
- Sensex rangebound, Nifty below 7800; top fifteen stocks in focusThe Sensex was trading in a rage with a negative bias in trade on Thursday, weighed down by losses in RIL, L&T, ICICI Bank, Tata Motors and...
- Fifteen stocks in focus in Thursday morning tradeIndian markets are expected to trade in a range. Here is a list of fifteen stocks which are likely to be in focus today.
- Strides Arcolab gets USFDA approval for Tacrolimus capsulesThe product will be manufactured at the company's oral dosage facility at Bangalore and marketed directly by Strides in the US market.
- Strides Arcolab gets USFDA approval to sell transplant drugThe capsule is an immuno-suppressant used for preventing organ rejection in certain patients following liver, kidney, or heart transplant.
- Panacea Biotech enters into pact with Kremers Urban; stock upShares of Panacea Biotech gained momentum after the company entered into strategic alliance with Kremers Urban for 11 high barrier to entry...
Load More
